Paper25473151
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization.
Vercauteren K and 3 others. World J Gastroenterol, 2014. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. Papers, record 25473151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25473151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neutralizing | Major topic |
| Hepacivirus | Major topic |
| Hepatitis C Antibodies | Major topic |
| Hepatitis C, Chronic | Major topic |
| Lipids | Major topic |
| Lipoproteins | Major topic |
| Liver | Major topic |
| Virus Internalization | Major topic |
| Animals | |
| Antiviral Agents | |
| Host-Pathogen Interactions | |
| Humans | |
| Liver Transplantation | |
| Treatment Outcome | |
| Virulence | |
| Virus Activation |
Source PubMed
References161
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16641285 | Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry. | J Virol | 2006 | https://conductscience.org/library/papers/16641285 | PubMed |
| 2 | 20568303 | Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy. | Hepatology | 2010 | https://conductscience.org/library/papers/20568303 | PubMed |
| 3 | 19793818 | Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. | J Virol | 2009 | https://conductscience.org/library/papers/19793818 | PubMed |
| 4 | 19902246 | Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation. | Med Microbiol Immunol | 2010 | https://conductscience.org/library/papers/19902246 | PubMed |
| 5 | 22300469 | Antiviral strategies in hepatitis C virus infection. | J Hepatol | 2012 | https://conductscience.org/library/papers/22300469 | PubMed |
| 6 | 20826689 | Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. | J Virol | 2010 | https://conductscience.org/library/papers/20826689 | PubMed |
| 7 | 17517063 | Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. | Cell Microbiol | 2007 | https://conductscience.org/library/papers/17517063 | PubMed |
| 8 | 18000990 | Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. | Hepatology | 2007 | https://conductscience.org/library/papers/18000990 | PubMed |
| 9 | 8121333 | Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. | Med Microbiol Immunol | 1993 | https://conductscience.org/library/papers/8121333 | PubMed |
| 10 | 19215577 | Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients. | J Viral Hepat | 2009 | https://conductscience.org/library/papers/19215577 | PubMed |
| 11 | 17329325 | Human serum amyloid A protein inhibits hepatitis C virus entry into cells. | J Virol | 2007 | https://conductscience.org/library/papers/17329325 | PubMed |
| 12 | 12483461 | Lipoprotein lipase: structure, function, regulation, and role in disease. | J Mol Med (Berl) | 2002 | https://conductscience.org/library/papers/12483461 | PubMed |
| 13 | 17571164 | Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17571164 | PubMed |
| 14 | 12210409 | Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. | J Med Virol | 2002 | https://conductscience.org/library/papers/12210409 | PubMed |
| 15 | 15767578 | Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15767578 | PubMed |
| 16 | 16476701 | The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. | FASEB J | 2006 | https://conductscience.org/library/papers/16476701 | PubMed |
| 17 | 19229312 | Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. | PLoS Pathog | 2009 | https://conductscience.org/library/papers/19229312 | PubMed |
| 18 | 10535997 | Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10535997 | PubMed |
| 19 | 17215280 | Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. | J Virol | 2007 | https://conductscience.org/library/papers/17215280 | PubMed |
| 20 | 16356932 | Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16356932 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41883448 | Very low-density lipoprotein and the human health. | World J Exp Med | 2026 | https://conductscience.org/library/papers/41883448 | PubMed |
| 41465470 | Epigenetic Mechanisms Involved in Hcv Infection and Human HCC. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465470 | PubMed |
| 35457118 | Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35457118 | PubMed |
| 35198567 | Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/35198567 | PubMed |
| 33925362 | Hepatitis C Virus Uses Host Lipids to Its Own Advantage. | Metabolites | 2021 | https://conductscience.org/library/papers/33925362 | PubMed |
| 31178869 | A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice. | Front Immunol | 2019 | https://conductscience.org/library/papers/31178869 | PubMed |
| 29527256 | Hepatitis C virus: Morphogenesis, infection and therapy. | World J Hepatol | 2018 | https://conductscience.org/library/papers/29527256 | PubMed |
| 29158310 | Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment. | Philos Trans R Soc Lond B Biol Sci | 2018 | https://conductscience.org/library/papers/29158310 | PubMed |
| 27338446 | Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance. | Viruses | 2016 | https://conductscience.org/library/papers/27338446 | PubMed |
| 26877603 | Hepatitis C virus relies on lipoproteins for its life cycle. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26877603 | PubMed |
| 26420957 | Chronic hepatitis C virus infection and lipoprotein metabolism. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26420957 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25473151
GET https://conductscience.org/api/papers/v1/25473151/references?page=2